Quinolone-resistant salmonella enterica serotype enteritidis infections associated with international travel

Clinical Infectious Diseases

Volumn 59, Issue 9, 2014, Pages e139-e141

  O'Donnell, Allison T ^a,b   Vieira, Antonio R ^b   Huang, Jennifer Y ^b   Whichard, Jean ^b   Cole, Dana ^b   Karp, Beth E ^b  

^a ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Drug resistance; foodborne diseases; quinolones; Salmonella; travel

Indexed keywords

ANTIINFECTIVE AGENT; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE ASSOCIATION; HUMAN; INTERNATIONAL TRAVEL; MAJOR CLINICAL STUDY; MONITORING; QUINOLONE RESISTANT SALMONELLA ENTERICA SEROTYPE ENTERITIDIS INFECTIONS; SALMONELLA ENTERITIDIS; SALMONELLOSIS; SEROTYPE; TRAVEL; UNITED STATES; DRUG EFFECTS; EMPORIATRICS; HEALTH SURVEY; INTERNATIONAL COOPERATION; MICROBIOLOGY; SALMONELLA ENTERICA SEROVAR ENTERITIDIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; INTERNATIONALITY; NALIDIXIC ACID; PUBLIC HEALTH SURVEILLANCE; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS; TRAVEL; TRAVEL MEDICINE; UNITED STATES;

EID: 84913537588     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu505     Document Type: Article

References (12)

1. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011; 17:7-15.
2. Centers for Disease Control and Prevention. Incidence and trends of infection with pathogens transmitted commonly through food-Foodborne Diseases Active Surveillance Network, 10 US sites, 1996-2012. MMWR Morb Mortal Wkly Rep 2013; 62:283-7.
3. Chai SJ, White PL, Lathrop SL, et al. Salmonella enterica serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis 2012; 54(suppl 5):S488-97.
4. Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): human isolates final report, 2010. Atlanta, Georgia: US Department of Health and Human Services, CDC, 2012.
5. US Food and Drug Administration. National Antimicrobial Resistance Monitoring System-Enteric Bacteria (NARMS): 2007 executive report. Rockville, MD: US Department of Health and Human Services, FDA, 2010.
6. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003; 37:75-81.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. CLSI document M100-S22. Wayne, PA: CLSI, 2012.
8. US Food and Drug Administration. National Antimicrobial Resistance Monitoring System-Enteric Bacteria (NARMS): 2010 executive report. Rockville, MD: US Department of Health and Human Services, FDA, 2012.
9. Kendall ME, Crim S, Fullerton K, et al. Travel-associated enteric infections diagnosed after return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009. Clin Infect Dis 2012; 54(suppl 5):S480-7.
10. Mølbak K, Gerner-Smidt P, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg Infect Dis 2002; 8:514-5.
11. Threlfall EJ, Day M, de Pinna E, Charlett A, Goodyear KL. Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004. Int J Antimicrob Agents 2006; 28:389-95.
12. Barza M, Travers K. Excess infections due to antimicrobial resistance: the "attributable fraction." Clin Infect Dis 2002; 34(suppl 3):S126-30.